Business
Myriad Genetics to Present Seven Studies at the 2019 National Society of Genetic Counselors Annual Meeting
SALT LAKE CITY, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, today
About this update from Myriad Genetics, Inc.
[{"type":"text","content":"SALT LAKE CITY, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, today announced that it will present results from seven studies at the 2019 National Society of Genetic Counselors (NSGC) annual meeting being held Nov. 5–8, 2019 in Salt Lake City.\"We are excited to present new data from seven studies at this year’s NSGC meeting,\" said Susan Manley, MS, CGC, MBA, senior vice president of Medical Services at Myriad Genetics. “Our presentations highlight the company’s commitment to advancing precision medicine in oncology and women’s health.” A list of presentations at 2019 NSGC is below. Please visit Myriad Genetics at booth #711 to learn more about our leading portfolio of precision medicine products. Follow Myriad on Twitter via @myriadgenetics and follow meeting news by using the hashtag #NSGC19.\n Featured Presentations at 2019 NSGCMyriad Product Abstract Author Poster Details myRisk® Hereditary Cancer RNA Research Program Continues to be a Valuable Tool in Variant ReclassificationSusana San RomanPoster (A-94)Tuesday, Nov. 5, 20195:45-7:00 p.m.Clinical Utility of Testing for PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D: Management Changes and Patient Adherence to Provider Recommendations Katie Johansen Taber Poster (A-97)Tuesday, Nov. 5, 20195:45-7:00 p.m. Foresight® Carrier Screen Fragile X Carrier Screening Accompanied by Genetic Consultation has Clinical Utility in Populations Beyond Those Recommended by Guidelines Katie Johansen Taber Podium (C-08)Thursday, Nov. 7, 201910:35-10:50 a.m. Classifying the Severity of Conditions on an Expanded Carrier Screening Panel Aishwarya ArjunanPoster (C-329)Thursday, Nov. 7, 20191:20-2:35 p.m.Minimizing Results Delivery Time for Couples Undergoing Carrier Screening by Using a Tandem-Submission-with-Partner-Reflex (“Tandem Reflex”) StrategyAishwarya ArjunanPoster (C-330)Thursday, Nov. 7, 20191:20-2:35 p.m. PrequelTM Prenatal ScreenWGS-based NIPS Without a Fetal Fraction Threshold: What are the Clinical Outcomes of No-Calls? Susan HancockPoster (A-334)Tuesday, Nov. 5, 20195:45-7:00 p.m.Expanded Aneuploidy Analysis Reveals Trisomy 2: Evidence of Rare Aneuploidy via NIPS Provides Opportunity for Focused Care Susan HancockPoster (C-315)Thursday, Nov. 7, 20191:20-2:35 p.m. About Myriad myRisk® Hereditary Can...